Cumulative Experience of Azimilide-Associated Torsades de Pointes Ventricular Tachycardia in the 19 Clinical Studies Comprising the Azimilide Database-Reference-Cited by-同舟云学术

Cumulative Experience of Azimilide-Associated Torsades de Pointes Ventricular Tachycardia in the 19 Clinical Studies Comprising the Azimilide Database

Published:2006-08 Issue:3 Volume:48 Page:471-477
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Pratt Craig M.,Al-Khalidi Hussein R.,Brum Jose M.,Holroyde Michael J.,Schwartz Peter J.,Marcello Stephen R.,Borggrefe Martin,Dorian Paul,Camm A. John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Pharmacology of azimilide dihydrochloride;Salata;Card Drug Rev,1997

2. Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter;Connolly;Am Heart J,2003

3. Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation;Connolly;Am J Cardiol,2001

4. Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators;Singer;J Am Coll Cardiol,2004

5. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator;Dorian;Circulation,2004

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ion Channel Methods in Cardiovascular Safety Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

2. Long QT begets long QT;Journal of Cardiovascular Electrophysiology;2022-11-15

3. Use of high throughput ion channel profiling and statistical modeling to predict off-target arrhythmia risk - One pharma's experience and perspective;Journal of Pharmacological and Toxicological Methods;2022-11

4. Drug-induced torsades de pointes;Torsades de Pointes;2022

5. Traditional risk factors for QT interval prolongation and torsades de pointes;Torsades de Pointes;2022